[go: up one dir, main page]

ATE230760T1 - Für staphylococcus aureus spezifischer antikörper und seine verwendung - Google Patents

Für staphylococcus aureus spezifischer antikörper und seine verwendung

Info

Publication number
ATE230760T1
ATE230760T1 AT97915542T AT97915542T ATE230760T1 AT E230760 T1 ATE230760 T1 AT E230760T1 AT 97915542 T AT97915542 T AT 97915542T AT 97915542 T AT97915542 T AT 97915542T AT E230760 T1 ATE230760 T1 AT E230760T1
Authority
AT
Austria
Prior art keywords
staphylococcus aureus
antibody specific
strains
antibody
immunoglobulins
Prior art date
Application number
AT97915542T
Other languages
English (en)
Inventor
Sylviane Merlin
Nicole Battail
Jean-Pierre Flandrois
Gerard Carret
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE230760T1 publication Critical patent/ATE230760T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97915542T 1996-03-21 1997-03-21 Für staphylococcus aureus spezifischer antikörper und seine verwendung ATE230760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603761A FR2746398B1 (fr) 1996-03-21 1996-03-21 Anticorps specifique de staphylococcus aureaus, et utilisations
PCT/FR1997/000510 WO1997034931A1 (fr) 1996-03-21 1997-03-21 Anticorps specifique de staphylococcus aureus et utilisations

Publications (1)

Publication Number Publication Date
ATE230760T1 true ATE230760T1 (de) 2003-01-15

Family

ID=9490562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915542T ATE230760T1 (de) 1996-03-21 1997-03-21 Für staphylococcus aureus spezifischer antikörper und seine verwendung

Country Status (10)

Country Link
US (1) US6340571B1 (de)
EP (1) EP0827512B1 (de)
JP (1) JP4213213B2 (de)
AT (1) ATE230760T1 (de)
CA (1) CA2221893C (de)
DE (1) DE69718261T2 (de)
ES (1) ES2188927T3 (de)
FR (1) FR2746398B1 (de)
PT (1) PT827512E (de)
WO (1) WO1997034931A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503015A (ja) * 1999-05-03 2003-01-28 メダレツクス・インコーポレーテツド スタフィロコッカス・アウレウスに対するヒト抗体
WO2001055218A1 (en) * 2000-01-31 2001-08-02 The Procter & Gamble Company Antibodies to the staphylococcal multidrug resistance (smr) protein
EP1695086B1 (de) * 2003-12-09 2009-02-18 BioMerieux, Inc. Verfahren zum nachweis bakterieller krankheitserreger
WO2005068647A2 (en) * 2003-12-09 2005-07-28 Biomerieux, Inc. Methods for detecting bacterial pathogens
US20100047252A1 (en) * 2006-11-22 2010-02-25 3M Innovative Properties Company Antibody with protein a selectivity
US7488807B2 (en) * 2006-11-22 2009-02-10 3M Innovative Properties Company Antibody with protein A selectivity
EP2240779A1 (de) * 2008-01-18 2010-10-20 3M Innovative Properties Company Verfahren zum nachweis eines analyts
CA2749501C (en) 2009-02-13 2017-01-10 Immunomedics, Inc. Immunoconjugates with an intracellularly-cleavable linkage
US9567379B2 (en) 2009-04-03 2017-02-14 The University Of Chicago Compositions and methods related to protein A (SpA) variants
JP5882892B2 (ja) * 2009-05-18 2016-03-09 ユリウス・マクシミリアンス−ウニヴェルジテート・ヴュルツブルクJulius Maximilians−Universitaet Wuerzburg 黄色ブドウ球菌エピトープIsaAまたはIsaBに対する抗体またはそれらのフラグメント
WO2011034660A1 (en) 2009-09-16 2011-03-24 Immunomedics, Inc. Class i anti-cea antibodies and uses thereof
CA2782194C (en) 2009-12-02 2018-01-16 Immunomedics, Inc. Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago プロテインA(SpA)変種に関連する組成物および方法
AU2012250924B2 (en) 2011-05-02 2017-05-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US9315567B2 (en) 2012-08-14 2016-04-19 Ibc Pharmaceuticals, Inc. T-cell redirecting bispecific antibodies for treatment of disease
DK2900277T3 (da) 2012-12-13 2022-04-04 Immunomedics Inc Doser af immunokonjugater af antistoffer og sn-38 til forbedret effektivitet og reduceret toksicitet
CN106132436B (zh) 2014-02-21 2021-06-15 Ibc药品公司 通过诱导对trop-2表达细胞的免疫应答的疾病疗法
EP3110445A4 (de) 2014-02-25 2017-09-27 Immunomedics, Inc. Humanisierter rfb4-anti-cd22-antikörper
US9580495B2 (en) 2014-06-24 2017-02-28 Immunomedics, Inc. Anti-histone therapy for vascular necrosis in severe glomerulonephritis
SI3204018T1 (sl) 2014-10-07 2021-11-30 Immunomedics, Inc. Neoadjuvantna uporaba konjugatov protitelo-zdravilo
WO2016172427A1 (en) 2015-04-22 2016-10-27 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
EP4257134A3 (de) 2015-06-25 2024-01-24 Immunomedics, Inc. Kombination von anti-hla-dr- oder anti-trop-2-antikörpern mit mikrotubuli-inhibitoren, parp-inhibitoren, bruton-kinase-inhibitoren oder phosphoinositol-3-kinase-inhibitoren zur signifikanten verbesserung des therapeutischen ergebnisses bei krebs
EP3316885B1 (de) 2015-07-01 2021-06-23 Immunomedics, Inc. Antikörper-sn-38-immunkonjugate mit einem cl2a-linker
WO2022239720A1 (ja) 2021-05-10 2022-11-17 公益財団法人川崎市産業振興財団 抗原への結合親和性を低減させた抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1231067A (en) * 1983-08-16 1988-01-05 Bioclones (Proprietary) Limited Monoclonal antibody to peroxidase and hybridoma producing it
FR2625321B1 (fr) * 1987-12-24 1992-10-02 Pasteur Institut Reactif pour le diagnostic de staphylococcus aureus par agglutination
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
FR2679923B1 (fr) * 1991-08-02 1993-10-22 Bio Merieux Reactif d'identification des bacteries de l'espece staphyloccocus aureus.

Also Published As

Publication number Publication date
DE69718261D1 (de) 2003-02-13
FR2746398A1 (fr) 1997-09-26
EP0827512A1 (de) 1998-03-11
CA2221893A1 (fr) 1997-09-25
PT827512E (pt) 2003-04-30
DE69718261T2 (de) 2003-09-04
WO1997034931A1 (fr) 1997-09-25
ES2188927T3 (es) 2003-07-01
EP0827512B1 (de) 2003-01-08
US6340571B1 (en) 2002-01-22
FR2746398B1 (fr) 1998-04-30
CA2221893C (fr) 2011-05-03
JP4213213B2 (ja) 2009-01-21
JPH11506026A (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
ATE230760T1 (de) Für staphylococcus aureus spezifischer antikörper und seine verwendung
ATE225670T1 (de) Antagonistische anti-avb3 integrin antikörper
ATE386116T1 (de) Bindungsdomänen des serrate-proteins
EP1423701A4 (de) Kreuzreaktive monoklonale und polyklonale antikörper, die oberflächenprotein aus koagulasenegativen staphylococci und staphylococcus aureus erkennen
FI956112A0 (fi) Monoklonaalinen anti- V-integriinivasta-aine
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
NZ334226A (en) Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
PT941121E (pt) Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
DE3486146D1 (de) Monoklonale antikoerper gegen endotoxine von gramnegativen bakterien.
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
EP1227159A4 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
NO972522D0 (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
BR9702101A (pt) Hibridoma e anticorpo monoclonal
DE3852914D1 (de) Monoklonale Antikörper und Diagnoseverfahren für Phytophthora-Infektionen.
EP0640621A3 (de) Monoklonaler Antikörper gegen Thrombin.
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
BR9305525A (pt) Teste de anticorpos para amilina
EP0450573A3 (de) Antikörper für die Behandlung und die Diagnose von Pseudomonas aeruginosa Infektionen
ATE289070T1 (de) Nachweisverfahren für microthrix parvicella
HUP0003029A2 (hu) Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk
DE69231058D1 (de) Hochaffine humanisierte monoklonale antikoerper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0827512

Country of ref document: EP